Skip to content

Prediction of Myocardial Injury After Non-Cardiac Surgery in Urologic Cancer Patients

Prediction of Myocardial Injury After Major Non-Cardiac Surgery in Patients With Urologic Cancer: A Prospective Multicenter Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07634666
Acronym
URO-MINS
Enrollment
200
Registered
2026-06-09
Start date
2026-07-15
Completion date
2028-12-31
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Adverse Cardiovascular Events (MACE), Myocardial Injury After Non-cardiac Surgery, Urologic Cancer

Keywords

Artificial Intelligence, Electrocardiography, Myocardial Injury After Non-cardiac Surgery, Major Adverse Cardiovascular Events, Perioperative Cardiovascular Risk, Urologic Cancer

Brief summary

This prospective multicenter observational study aims to evaluate the predictive value of artificial intelligence-based analysis of preoperative 12-lead electrocardiography for myocardial injury after non-cardiac surgery (MINS) and major adverse cardiovascular events (MACE) within 30 days after surgery in patients undergoing non-cardiac surgery for urologic cancer.

Detailed description

Myocardial injury after non-cardiac surgery (MINS) is associated with increased postoperative morbidity and mortality. Patients with urologic cancer undergoing major non-cardiac surgery may be at increased risk for perioperative cardiovascular complications. Early identification of patients at high risk for postoperative myocardial injury and adverse cardiovascular events may improve perioperative risk stratification and clinical management. This prospective multicenter observational study aims to evaluate the predictive value of artificial intelligence-based analysis of preoperative 12-lead electrocardiography for postoperative myocardial injury after non-cardiac surgery (MINS) and major adverse cardiovascular events (MACE) within 30 days after surgery in patients undergoing non-cardiac surgery for urologic cancer. Clinical characteristics, perioperative variables, electrocardiographic data, laboratory findings, and postoperative outcomes will be prospectively collected and analyzed to identify predictors of postoperative cardiovascular complications.

Interventions

This is a prospective observational study. No interventions are administered. Participants are followed for the development of myocardial injury after major non-cardiac surgery.

Sponsors

Korea University Anam Hospital
Lead SponsorOTHER
The Catholic University of Korea
CollaboratorOTHER
Keimyung University Dongsan Medical Center
CollaboratorOTHER
Medical AI Co., Ltd
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 60 years * Patients scheduled for major non-cardiac surgery under general anesthesia due to urologic cancer (e.g., radical prostatectomy, radical nephrectomy, partial nephrectomy) * Patients who undergo preoperative standard 12-lead electrocardiography * Patients classified as having intermediate or higher surgical risk * Patients who can be followed for at least 30 days postoperatively * Patients who voluntarily provide written informed consent to participate in this study

Exclusion criteria

* History of major adverse cardiovascular events (MACE) within 6 months prior to surgery * Inability to obtain essential clinical information required for study participation and follow-up * Patients who are not hospitalized after surgery * Individuals deemed inappropriate for participation in the study by the investigator due to legal or psychiatric reasons

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants with Myocardial Injury After Non-Cardiac Surgery (MINS)Intraoperative day and postoperative days 1-2 (within 3 days after surgery)Myocardial injury after non-cardiac surgery (MINS), defined as an elevation of fourth-generation cardiac troponin T measured on the day of surgery, postoperative day 1, and postoperative day 2 (within 3 days after surgery)

Secondary

MeasureTime frameDescription
Number of Participants with 30-Day Major Adverse Cardiovascular Events (MACE)Within 30 days after surgeryComposite of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke occurring within 30 days after surgery.

Countries

South Korea

Contacts

CONTACTDong Hyuck Cho, MD, PhD
why012@gmail.com+82-2-920-5448
CONTACTJong-Chan Youn, MD, PhD
jong.chan.youn@gmail.com+82-2-2258-6145
PRINCIPAL_INVESTIGATORDong Hyuck Cho, MD, PhD

Korea University Anam Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026